OpenArc Corporate Advisory, LLC

SEC CIK: 0002111345
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

KNSA holding history

Kiniksa Pharmaceuticals International, plc in every 13F filed by OpenArc Corporate Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KNSA overview All 13F holders of KNSA Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2025

Holdings of KNSA by OpenArc Corporate Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−48,353−100.0%	Sold out	Holders
Q1 2026	48,353	$2.33M	<0.1%	+14,491+42.8%	Added	Holders
Q4 2025	33,862	$1.40M	<0.1%	–	No prior filing	Holders